Here you will find the last news about TAVR

1) New Study Confirms TAVR Durability at 5 Years

The ADVANCE study was designed to evaluate the safety and effectiveness of transcatheter aortic valve replacement (TAVR) with self-expanding prosthesis CoreValve in “real world” patients with symptomatic, severe aortic stenosis at high surgical risk.

Read the conclusions of this study

 

2) An Important Study Shows That Renal Function Must Be Cared for in TAVR

Renal impairment affects 25% of all patients who undergo TAVR. In this sense, evidence on the relation between TAVR and this condition is still limited, particularly as regards patients who require dialysis.

Read more on this study

 

3) End of Discussion on the Impact of Pacemaker After TAVR?

Pacemaker implantation after TAVR is quite common. However, its short- and long-term clinical impact is still controversial. This study is the largest meta-analysis so far on the relation between TAVR and pacemaker implantation, and it offers interesting conclusions regarding both short- and long-term outcomes.

Read the full abstract 

 

4) It Is a Fact: Cerebral Protection in TAVR Has Proved to Reduce Stroke and Death

This work upholds the idea that cerebral protection devices in patients who have undergone TAVR through a transfemoral access reduce significantly the risk for stroke and death.

Read the full abstract 

 

5) Conscious Sedation in TAVR: Is It Advisable?

Conscious sedation during TAVR offers the advantage of reducing the time spent in the cath lab and in the critical care unit, the global duration of hospital stay, and, obviously, costs. However, there still are questions on the safety of this strategy compared to general anesthesia.

This study sheds light on these issues. Read it 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...